TCL Archive In Brief: FDA Opens Advisory Committee Consideration Of NDAs, Finds Discussion Is Not Inhibited September 10, 1976
TCL Archive Dramatic responses to Iressa prompted further bench research. Results have limited clinical relevance, for now, but findings may explain failure of INTACT studies. April 30, 2004
TCL Archive House Committee Provides $21 Billion to NCI, Deletes Breast Cancer Earmark, Forward Funding July 2, 1993
